3-(1-((3,5-DIMETHYLISOXAZOL-4-YL)METHYL)-1H-PYRAZOL-4-YL)-1-(3-HYDROXYBENZYL)-IMIDAZOLIDINE-2,4-DIONE
UNII 1P43YY1KO2
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1h-pyrazol-4-yl)-1-(3-hydroxybenzyl)-imidazolidine-2,4-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1P43YY1KO2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1119831-25-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H19N5O4 LLJBKECMPVCSDS-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1h-pyrazol-4-yl)-1-(3-hydroxybenzyl)-imidazolidine-2,4-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.